Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued
Source: SeekingAlpha
2025-08-08 14:58:37 ET
Investment Overview - Understanding Sana's Allogeneic Cell Therapy Breakthrough In Type 1 Diabetes
Read the full article on Seeking Alpha
For further details see:
Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued
Sana Biotechnology Inc.
NASDAQ: SANA
SANA Trading
1.43% G/L:
$3.185 Last:
1,216,540 Volume:
$3.17 Open:
SANA Latest News
March 13, 2026 09:00:00 am
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
March 03, 2026 04:05:00 pm
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
SANA Stock Data
$1,021,514,070
186,189,918
2.26%
60
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle
